DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2310103/pharma-stock-roundup-azn-sny-abbv-q2-earnings-pfe-mrk-s-positive-pipeline-news?cid=CS-ZC-FT-analyst_blog|stock_roundup-2310103 Jul 26, 2024 - AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals. 0

https://www.fool.com/earnings/call-transcripts/2024/07/25/abbvie-abbv-q2-2024-earnings-call-transcript/?source=iedfolrf0000001 Jul 25, 2024 - ABBV earnings call for the period ending June 30, 2024. 0

https://www.zacks.com/stock/news/2306101/first-full-week-of-q2-earnings-pce-out-friday?cid=CS-ZC-FT-ahead_of_wall_street-2306101 Jul 22, 2024 - No fewer than 845 companies are scheduled to report this week, including Alphabet (GOOGL) and Tesla (TSLA) Tuesday. 0

https://www.zacks.com/stock/news/2305599/abbvie-abbv-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2305599 Jul 19, 2024 - AbbVie (ABBV) closed at $172.32 in the latest trading session, marking a +0.69% move from the prior day. 0

https://www.fool.com/investing/2024/07/17/3-absurdly-cheap-stocks-to-buy-and-hold-for-years/?source=iedfolrf0000001 Jul 17, 2024 - You can buy these solid stocks at some attractive discounts right now. 0

https://www.fool.com/investing/2024/07/15/want-decades-of-passive-income-3-stocks-to-buy-now/?source=iedfolrf0000001 Jul 15, 2024 - These companies stand out for their pedigrees, robust financials, and future growth prospects. 0

https://www.zacks.com/commentary/2299156/top-stock-reports-for-novo-nordisk-abbvie-astrazeneca?cid=CS-ZC-FT-research_daily-2299156 Jul 10, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AbbVie Inc. (ABBV) and AstraZeneca PLC (AZN), as well as two micro-cap stocks, Air T, Inc. (AIRT) and United-Guardian, Inc. (UG). 0

https://www.zacks.com/stock/news/2298543/eli-lilly-lly-to-buy-morphic-for-3-2b-boost-ibd-presence?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2298543 Jul 09, 2024 - Eli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding the latter's lead candidate, MORF-057, which is being developed for IBD conditions. 0

https://www.fool.com/investing/2024/07/08/the-smartest-dividend-stocks-to-buy-with-250-right/?source=iedfolrf0000001 Jul 08, 2024 - $250 will go a long way with these great dividend stocks. 0

https://www.zacks.com/stock/news/2296547/company-news-for-jul-3-2024?cid=CS-ZC-FT-corporate_summary-2296547 Jul 03, 2024 - Companies in The News Are: TSLA, AAPL, IQ, ABBV 0